期刊文献+

抗CCP联合RF检测对诊断类风湿关节炎的应用价值 被引量:4

原文传递
导出
摘要 目的:评价抗环瓜氨酸肽(CCP)抗体检测对类风湿关节炎(RA)的诊断意义。方法:RA组患者90例,非RA组患者78例,另外有健康体检者60例。检测各组患者血清中的抗CCP抗体和RF,并对2组结果进行敏感性和特异性的比较。结果:抗CCP的敏感性和特异性分别为68.89%、97.10%,RF的敏感性和特异性分别为86.67%、78.99%,二者联合检测的敏感性和特异性分别为65.56%、97.83%。结论:两者联合检测,可显著提高诊断RA的特异性,有助于提高对RA患者的早期诊断的准确性。
出处 《中国伤残医学》 2013年第6期271-271,共1页 Chinese Journal of Trauma and Disability Medicine
  • 相关文献

参考文献5

  • 1左小霞,陶立坚,高洁生.主译,凯利风湿病学[M].北京:人民卫生出版社,2006:929.
  • 2胡学芳,魏华.抗环瓜氨酸肽抗体在类风湿关节炎中的临床意义[J].中华检验学杂志,2003,26(8):484-486.
  • 3Matsui T, Shimada K, Ozawa N, etal. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis[J]. Rheumatology ,2006,33(22):2390-2397.
  • 4Vossenaar ER, van Venrooij WJ. Anti-CCP antibodies, a highly specific marker for (early) rheumatoid arthritis[J].Clin Applied Immunol Rev, 2004,4: 239-262.
  • 5牛红青,李小峰,张莉芸,刘雅妮,茹晋丽,胡学芳.抗环瓜氨酸肽抗体与类风湿关节炎疾病活动及骨侵蚀关系的研究[J].中华风湿病学杂志,2008,12(9):603-605. 被引量:28

二级参考文献11

  • 1Bas S, Perneger TV, Seitz M, et al. Diagnostic tests for rheumatoid arthritis: comparison of anti-cycLic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factor. Rheumatology (Oxford), 2002, 41: 809-814.
  • 2Schellekens GA, Visser H, de Jong BAW, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum, 2000, 43: 155-163.
  • 3Lee DM, Schur PH. Clinical utility of the anti-CCP assay in patients with rheumatic disease. Ann Rheum Dis, 2003, 62: 870-874.
  • 4Van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum, 2004, 50: 709-715.
  • 5Silveira IG, Burlingame RW, yon Muhlen CA, et al. Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF. Clin Rheumatol, 2007, 26: 1883-1889.
  • 6Quinn MA, Goagh AK, Green M J, et al. Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. Rheumatology ( Oxford ), 2006, 45:478 -480.
  • 7del Val del Amo N, Ibanez-Bosch R, Fito-Manteca C, et al. Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness. Clin Exp Rheumatol, 2006, 24: 281-286.
  • 8Inanc N, Dalkilic E, Kamali S, et al. Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis. Clin Rheumatol, 2007, 26: 17-23.
  • 9Bas S, Genevay S, Meyer O, et al. Anti-cyclic citrullinated peptide antibodies, IgM and lgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology (Oxford), 2003, 42: 677-680.
  • 10Van der Hehn-van Mil AH, Verpoort KN, Breedveld FC, et al. Antibodies to citrullinated proteins and differences in clinical prngression of rheumatoid arthritis. Arthritis Res Ther, 2005, 7: 949-958.

共引文献29

同被引文献24

引证文献4

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部